• Return to Headlines

Best Relative Performance in the Pharmaceuticals Industry Detected in Shares of Vivus (VVUS, VRX, VPHM, ELN, NVO)

Written on Mon, 11/07/2011 - 6:29am
By David Diaz

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the potential to outperform.
Vivus (NASDAQ:VVUS) ranks first with a gain of 4.53%; Valeant Pharmaceuticals International (NYSE:VRX) ranks second with a gain of 1.77%; and Viropharma (NASDAQ:VPHM) ranks third with a gain of 0.82%.
Elan (NYSE:ELN) follows with a gain of 0.34% and Novo Nordisk (NYSE:NVO) rounds out the top five with a gain of 0.32%.
SmarTrend currently has shares of Vivus in an Uptrend and issued the Uptrend alert on August 29, 2011 at $7.75. The stock has risen 27.9% since the Uptrend alert was issued.

Keywords: Vivus relative performance

Ticker(s): VVUS VRX VPHM ELN NVO

Contact David Diaz



Smartrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.mysmartrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at http://www.mysmartrend.com/morning-call-newsletter-signup.